BioQuest Corp.
BQST · OTC
10/31/2025 | 7/31/2025 | 4/30/2025 | 1/31/2025 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 1.43 | 0.49 | -0.09 | -0.08 |
| FCF Yield | -0.64% | 0.00% | -2.49% | 0.00% |
| EV / EBITDA | -573.83 | -123.25 | -48.39 | 0.00 |
| Quality | ||||
| ROIC | 9.66% | 36.62% | -118.44% | 0.00% |
| Gross Margin | 74.71% | -648.00% | 29.04% | 0.00% |
| Cash Conversion Ratio | 2.65 | 1.19 | 0.74 | – |
| Growth | ||||
| Revenue 3-Year CAGR | 605,363.07% | 546,247.14% | 524,504.09% | -100.00% |
| Free Cash Flow Growth | 0.00% | 0.00% | 0.00% | 0.00% |
| Safety | ||||
| Net Debt / EBITDA | -7.19 | -1.58 | -0.62 | 0.00 |
| Interest Coverage | -2.73 | -17.29 | 0.00 | -11.47 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | -1,227.13 | -148.36 | -161.34 | 0.00 |